BIODESIX, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
BIODESIX, INC. (BDSX) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 1.33 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-05
- BIODESIX, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 1.33M shares, a 38.57% increase year-over-year.
- BIODESIX, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 1.34M shares, a 45.85% increase year-over-year.
- BIODESIX, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 935.00K shares, a 35.70% increase year-over-year.
- BIODESIX, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 962.00K shares, a 93.56% decline year-over-year.
- BIODESIX, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 951.00K shares, a 36.05% increase from fiscal 2024.
- BIODESIX, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 699.00K shares, a 93.91% decline from fiscal 2023.
- BIODESIX, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 11.48M shares, a 21.36% increase from fiscal 2022.
- BIODESIX, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 9.46M shares, a 167.64% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 1.33M shares 10-Q · filed 2026-08-05 | 1.33M shares 10-Q · filed 2026-08-05 | ||||||
| 2026-03-31 | 1.34M shares 10-Q · filed 2026-05-04 | |||||||
| 2025-12-31 | 951.00K shares 10-K · filed 2026-02-26 | |||||||
| 2025-09-30 | 935.00K shares 10-Q · filed 2025-11-03 | 935.00K shares 10-Q · filed 2025-11-03 | ||||||
| 2025-06-30 | 962.00K shares 10-Q · filed 2026-08-05 | 19.24M shares 10-Q · filed 2025-08-07 | 962.00K shares 10-Q · filed 2026-08-05 | 19.24M shares 10-Q · filed 2025-08-07 | ||||
| 2025-03-31 | 916.00K shares 10-Q · filed 2026-05-04 | 18.32M shares 10-Q · filed 2025-05-13 | ||||||
| 2024-12-31 | 699.00K shares 10-K · filed 2026-02-26 | 14.01M shares 10-K · filed 2025-03-03 | ||||||
| 2024-09-30 | 689.00K shares 10-Q · filed 2025-11-03 | 13.80M shares 10-Q · filed 2024-11-01 | 689.00K shares 10-Q · filed 2025-11-03 | 13.80M shares 10-Q · filed 2024-11-01 | ||||
| 2024-06-30 | 14.94M shares 10-Q · filed 2025-08-07 | 14.94M shares 10-Q · filed 2025-08-07 | ||||||
| 2024-03-31 | 14.27M shares 10-Q · filed 2025-05-13 | |||||||
| 2023-12-31 | 11.48M shares 10-K · filed 2025-03-03 | |||||||
| 2023-09-30 | 11.65M shares 10-Q · filed 2024-11-01 | 11.65K shares 10-Q · filed 2023-11-07 | 11.65M shares 10-Q · filed 2024-11-01 | 11.65K shares 10-Q · filed 2023-11-07 | ||||
| 2023-06-30 | 12.56M shares 10-Q · filed 2024-08-07 | 12.56M shares 10-Q · filed 2024-08-07 | ||||||
| 2023-03-31 | 12.63M shares 10-Q · filed 2024-05-08 | |||||||
| 2022-12-31 | 9.46M shares 10-K · filed 2024-03-01 | |||||||
| 2022-09-30 | 4.75M shares 10-Q · filed 2023-11-07 | 4.75M shares 10-Q · filed 2023-11-07 | ||||||
| 2022-06-30 | 5.10M shares 10-Q · filed 2023-08-07 | 5.10M shares 10-Q · filed 2023-08-07 | ||||||
| 2022-03-31 | 4.70M shares 10-Q · filed 2023-05-11 | |||||||
| 2021-12-31 | 3.54M shares 10-K · filed 2023-03-06 | |||||||
| 2021-09-30 | 3.09M shares 10-Q · filed 2022-11-03 | 3.09M shares 10-Q · filed 2022-11-03 | ||||||
| 2021-06-30 | 3.10M shares 10-Q · filed 2022-08-04 | 3.10M shares 10-Q · filed 2022-08-04 | ||||||
| 2021-03-31 | 3.09M shares 10-Q · filed 2022-05-11 | |||||||
| 2020-12-31 | 2.68M shares 10-K · filed 2022-03-14 | |||||||
| 2020-09-30 | 143.54M shares 10-Q · filed 2021-11-15 | 143.54M shares 10-Q · filed 2021-11-15 | ||||||
| 2020-06-30 | 165.51M shares 10-Q · filed 2021-08-10 | 165.51M shares 10-Q · filed 2021-08-10 | ||||||
| 2020-03-31 | 156.81M shares 10-Q · filed 2021-05-11 | |||||||
| 2019-12-31 | 144.06M shares 10-K · filed 2021-03-16 | |||||||
| 2019-09-30 | 139.97M shares 10-Q · filed 2020-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |